A perspective on diuretic resistance in chronic congestive heart failure.

St. Francis Hospital, The Heart Center ®, Center for Advanced Cardiac Therapeutics, Roslyn, NY, USA. Brown University, College of Arts and Sciences, Providence, RI, USA. Icahn School of Medicine, Mount Sinai Hospital Center, New York, NY, USA. St. Francis Hospital, The Heart Center®, Center for Advanced Cardiac Therapeutics, 100 Port Washington Boulevard, Roslyn, NY 11576-1348, USA.

Therapeutic advances in cardiovascular disease. 2017;(10):271-278
Full text from:

Abstract

Chronic congestive heart failure (CHF) is a complex disorder characterized by inability of the heart to keep up the demands on it, followed by the progressive pump failure and fluid accumulation. Although the loop diuretics are widely used in heart failure (HF) patients, both pharmacodynamic and pharmacokinetic alterations are thought to be responsible for diuretic resistance in these patients. Strategies to overcome diuretic resistance include sodium intake restriction, changes in diuretic dose and route of administration and sequential nephron diuretic therapy. In this review, we discuss the definition, prevalence, mechanism of development and management strategies of diuretic resistance in HF patients.

Methodological quality

Publication Type : Review

Metadata

MeSH terms : Diuresis ; Hemodynamics